Geode Capital Management’s Anebulo Pharmaceuticals ANEB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $296K | Buy |
205,720
+302
| +0.1% | +$435 | ﹤0.01% | 3739 |
|
|
2025
Q1 | $267K | Buy |
205,418
+114,077
| +125% | +$148K | ﹤0.01% | 3754 |
|
|
2024
Q4 | $153K | Buy |
91,341
+3,551
| +4% | +$5.97K | ﹤0.01% | 3975 |
|
|
2024
Q3 | $169K | Buy |
87,790
+36,482
| +71% | +$70.4K | ﹤0.01% | 3958 |
|
|
2024
Q2 | $140K | Buy |
51,308
+28,531
| +125% | +$77.9K | ﹤0.01% | 4036 |
|
|
2024
Q1 | $65.4K | Buy |
+22,777
| New | +$65.4K | ﹤0.01% | 4264 |
|